Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05230810 |
| Title | Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer. |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | Yes |
| Sponsors | Criterium, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Colorado Cancer Center | RECRUITING | Aurora | Colorado | 80045 | United States | Details |
| Cancer Care & Hematology-Fort Collins | RECRUITING | Fort Collins | Colorado | 80528 | United States | Details |
| Louisiana State University Health Sciences Center | RECRUITING | New Orleans | Louisiana | 70112 | United States | Details |
| University of Wisconsin Carbone Cancer Center | RECRUITING | Madison | Wisconsin | 53792 | United States | Details |